medigraphic.com
ISSN 1561-302X (Print)

2022, Number 1

<< Back Next >>

Rev cubana med 2022; 61 (1)

The pos-COVID-19 syndrome in patients with coronavirus disease

Hierrezuelo RN, Cardero CF, Carbó CY

Language: Spanish
References: 24
Page: 1-11
PDF size: 287.21 Kb.


ABSTRACT

Introduction: Postcovid syndrome is a new and unique phenomenon. Its symptoms, particularly extreme fatigue, can have knock-on effects on a person's quality of life.
Objective: To describe some clinical and epidemiological characteristics of patients with post-COVID-19 syndrome.
Methods: We conducted a retrospective descriptive study of 159 patients who attended the convalescent consultation for patients with COVID-19 from April to June 2021 at Ramón López Peña Community Polyclinic in Santiago de Cuba.
Results: The largest number of diagnosed was 66 patients (41.5%) and symptoms lasted from 15 to 30 days after the acute phase of the disease (62.2%). The female sex prevailed in 65.4% and the age group ranged 50 to 59 years (43.4%). Arterial hypertension and diabetes mellitus were the comorbidities with the highest incidence in the casuistry in 41.9% and 27.2%, respectively. Fatigue, headache and psychological disorders were the most significant prolonged symptoms in 58.2%, 44.5% and 35.6% respectively.
Conclusions: Among the patients followed up in the convalescent consultation for COVID-19, the proportion of presence of comorbidities is higher and fatigue is the most frequent complaint.


REFERENCES

  1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CHQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. DOI: https://pubmed.ncbi.nlm.nih.gov/32109013

  2. Teneforde MW, Kim S, Lindsell CJ, Billing E, Shapiro N, File DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network 2020. MMWR. 2020. Disponible en: https://doi.org/10.15585/mmwr.mm6930e1

  3. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. 2020[acceso: 23/06/2021]. Disponible en: Disponible en: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications

  4. Otte M, Klussmann J, Luers J. Persisting olfactory dysfunction in patients after recovering from COVID-19. J Infect. 2020[acceso: 18/05/2021];81(3):e58. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32592702

  5. Davis HE, McCorkell AL, WeiRyan HL, Re'emSigne Redfield LY, Akrami AA. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. MedRxiv. 2020[acceso: 22/05/2021]. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/34308300

  6. COVID-19 (coronavirus): Efectos a largo plazo. Mayo Clinic. 2021[acceso: 23/05/2021]. Disponible en: Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351

  7. Herrera JC, Arellano EI, Juárez LI, Contreras RI. Persistencia de síntomas en pacientes después de la enfermedad por coronavirus (COVID-19) en un hospital de tercer nivel de Puebla, México. Med Int Méx. 2020;36(6):789-93. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=96464

  8. Pérez D, Medina D, Aluán A, González L, Cuenca E, López E, et al. Caracterización y permanencia de signos y síntomas en pacientes COVID-19 positivos y negativos que acuden al Consultorio de Neumología del Hospital General de Luque, Paraguay. Revista De Salud Pública Del Paraguay. 2021[acceso: 28/06/2021];11(1):41-47. Disponible en: Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2307-33492021000100041

  9. Wise J. Covid-19: Symptoms are common after acute phase of disease, Italian study shows. BMJ. 2020;370: 2804. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32651164

  10. Darley DR, Candidate PhD, Dore GJ, Cysique L, Wilhelm KA, Andresen D, et al. High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection. Research Letter. The Medical Journal of Australia. 2020[acceso: 12/07/2021]. Disponible en: Disponible en: https://www.mja.com.au/journal/2020/high-rate-persistent-symptoms-4-months-after-community-and-hospital-managed-sars-cov-2

  11. Rosales A, García C, Mediavilla JD. Persistent symptoms after acute COVID-19 infection: importance of follow-up. Med Clin (Barc). 2021;156(1):35-36. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33077167

  12. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Síntomas de posdiscargo y necesidades de rehabilitación en sobrevivientes de la infección COVID‐19: una evaluación transversal. J Med Virol. 2020:110. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/jmv.26368

  13. Nehme M, Braillard O, Alcoba G, Perone SA, Courvoisier MD, Chappuis F, et al. COVID-19 Síntomas: Evolución longitudinal y persistencia en entornos ambulatorios. Ann Intern. 2020[acceso: 26/07/2021]. Disponible en: Disponible en: https://www.acpjournals.org/doi/10.7326/M20-5926

  14. Yusuke M, Shinichiro M, Shinya T, Masako A, Yasuyo O, Keiko T, et al. Prolonged and Late-Onset Symptoms of Coronavirus Disease. Open Forum Infectious Diseases. 2020;7(11):507. DOI: https://doi.org/10.1093/ofid/ofaa507

  15. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020[acceso: 28/07/2021];20(10):1115-7. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32888409

  16. Fieiras C, Panoso CN, Rosell CI, Franco JVA. Manejo de los síntomas persistentes de COVID-19 en atención primaria. Evid actual pract ambul. 2020[acceso: 16/07/2021];23(4):e002103. Disponible en: Disponible en: https://www.evidencia.org/index.php/Evidencia/article/view/6895

  17. Carfì A, Bernabei R, Landi FG. Against COVID-19 .Post-Acute Care Study Group: for the Gemelli Against CCOVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32644129

  18. Sociedad Española de Médicos Generales y de Familia. COVID-19 persistente. Encuesta. 2020[acceso: 21/03/2021]. Disponible en: Disponible en: https://www.semg.es/images/2020/Noticias/20201111_Resultados_Encuesta_COVID_Persistente.pdf

  19. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodríguez A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020[acceso: 16/07/2021];277(1):2251-61. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32253535

  20. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020[acceso: 12/07/2021];55(6):2001217. Disponible en:Disponible en: https://pubmed.ncbi.nlm.nih.gov/32381497

  21. You J, Zhang L, Ni-Jia-Ti M, Zhang J, Hu F, Chen L, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infect. 2020[acceso: 15/07/2021];81(2):150-52. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273134

  22. Martín MC, García L, Mateos A. Sobrevivir a las unidades de cuidados intensivos mirando a través de los ojos de la familia. Med Intensiva. 2017[acceso: 16/07/2021];41(8):451-53. Disponible en: Disponible en: https://www.medintensiva.org/es-sobrevivir-las-unidades-cuidados-intensivos-articulo-S0210569117300657

  23. Cuba. Centro Nacional de Información de Ciencias Médicas/INFOMED. Ministerio de Salud Pública: nueva versión del Protocolo de Actuación Nacional para la COVID-19. La Habana. 2020[acceso: 26/12/2020]. Disponible en: Disponible en: http://www.infomed.ijv.sld.cu/anuncio/2021/03/29/ministerio-de-salud-publica-nueva-version-del-protocolo-de-actuacion-nacional-par

  24. Carrara C. Persistencia de síntomas en pacientes con COVID-19. Evidencia, actualización en la práctica Ambulatoria. 2020;23(3):e002083. Disponible en: https://www.evidencia.org/index.php/Evidencia




2020     |     www.medigraphic.com